Amicus Therapeutics Inc.

(FOLD) Trade

By |

Profile

Amicus Therapeutics Inc is a biotechnology company. It is engaged in the discovery, development, and commercialization of medicines for various rare metabolic diseases. The firm offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 1/2 (ATB200-02) and Phase 3 (ATB200-03) clinical studies for an investigational enzyme replacement therapy (AT-GAA) for Pompe disease. Amicus Therapeutics has a strategic manufacturing collaboration with Thermo Fisher Scientific for conducting preclinical and clinical-stage gene therapy programs for CLN6, CLN3, and other Batten disease programs.

Contact Information

Website: www.amicusrx.com
Email: info@amicusrx.co.uk
Main Phone: +1 609 662-2000
Address: 1 Cedar Brook Drive
State: NJ
City / Town: Cranbury
Country: USA
Postal Code: 08512

Issuer Information

Exchange: NSD
CEO: John F. Crowley
Employees: 584
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Amicus Therapeutics Inc is a biotechnology company. It is engaged in the discovery, development, and commercialization of medicines for various rare metabolic diseases. The firm offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 1/2 (ATB200-02) and Phase 3 (ATB200-03) clinical studies for an investigational enzyme replacement therapy (AT-GAA) for Pompe disease. Amicus Therapeutics has a strategic manufacturing collaboration with Thermo Fisher Scientific for conducting preclinical and clinical-stage gene therapy programs for CLN6, CLN3, and other Batten disease programs.

Contact Information

Website: www.amicusrx.com
Email: info@amicusrx.co.uk
Main Phone: +1 609 662-2000
Address: 1 Cedar Brook Drive
State: NJ
City / Town: Cranbury
Country: USA
Postal Code: 08512

Issuer Information

Exchange: NSD
CEO: John F. Crowley
Employees: 584
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 10.41 $ 0.38 (3.79%)
Last Price 10.41 Change $ 0.38 Change % 3.79 Tick N/A
Bid 10.41 Bid Size 100.00 Ask 10.90 Ask Size 100.00
Open 10.25 High 10.48 Low 10.09 Prev Close 10.03
Last Trade Volume 3.3 mi 52 Wk Hi 14.29 52 Wk Low 6.25
Market Cap 2.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 257,244,659.00 EPS (TTM) -1.51 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 22 110
Number of Buys 13 61
Number of Sells 9 49
Net Activity -78433 2199222
Last 10 Buys Shares
Edelman Joseph 1,000
Edelman Joseph 1,000
Edelman Joseph 1,000
Edelman Joseph 1,000
Ellen S. Rosenberg 1,000
Margaret G. McGlynn 1,000
Edelman Joseph 1,000
Edelman Joseph 1,000
Edelman Joseph 1,000
Edelman Joseph 1,000
Last 10 Sell Shares
Hung Do 1,000
Hung Do 1,000
Margaret G. McGlynn 1,000
Jay Barth 1,000
Hung Do 1,000
Michael G. Raab 1,000
Jay Barth 1,000
Kurt J. Andrews 1,000
William D. Baird 1,000
Jay Barth 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 22 22 22 22
Low Target Price Estimate 18.5 18.5 18.5 18.5
Mean Target Price Estimate 20.08 20.08 20.08 20.08
Standard Deviation 1.56 1.56 1.56 1.56
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 05/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1